No takes yet. Share an insight, caveat, or question.
Review finds negligible infection risk from lactobacilli and bifidobacteria probiotics across all populations, highlighting their broad clinical safety.
Borriello et al. (2003) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: